{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:03:07Z","timestamp":1793041387372,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Analysis of exhaled breath for asthma phenotyping using endogenously generated volatile organic compounds (VOCs) offers the possibility of noninvasive diagnosis and therapeutic monitoring. Induced sputum is indeed not widely available and markers of neutrophilic asthma are still lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine whether analysis of exhaled breath using endogenously generated VOCs can be a surrogate marker for recognition of sputum inflammatory phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective study on 521 patients with asthma recruited from the University Asthma Clinic of Liege. Patients underwent VOC measurement, fraction of exhaled nitric oxide (FeNO) spirometry, sputum induction, and gave a blood sample. Subjects with asthma were classified in three inflammatory phenotypes according to their sputum granulocytic cell count.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>In the discovery study, seven potential biomarkers were highlighted by gas chromatography\u2013mass spectrometry in a training cohort of 276 patients with asthma. In the replication study (n\u2009=\u2009245), we confirmed four VOCs of interest to discriminate among asthma inflammatory phenotypes using comprehensive two-dimensional gas chromatography coupled to high-resolution time-of-flight mass spectrometry. Hexane and 2-hexanone were identified as compounds with the highest classification performance in eosinophilic asthma with accuracy comparable to that of blood eosinophils and FeNO. Moreover, the combination of FeNO, blood eosinophils, and VOCs gave a very good prediction of eosinophilic asthma (area under the receiver operating characteristic curve, 0.9). For neutrophilic asthma, the combination of nonanal, 1-propanol, and hexane had a classification performance similar to FeNO or blood eosinophils in eosinophilic asthma. Those compounds were found in higher levels in neutrophilic asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study is the first attempt to characterize VOCs according to sputum granulocytic profile in a large population of patients with asthma and provide surrogate markers for neutrophilic asthma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201811-2210oc","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T15:37:07Z","timestamp":1554997027000},"page":"444-453","source":"Crossref","is-referenced-by-count":163,"title":["Exhaled Volatile Organic Compounds Are Able to Discriminate between Neutrophilic and Eosinophilic Asthma"],"prefix":"10.1093","volume":"200","author":[{"given":"Florence N.","family":"Schleich","sequence":"first","affiliation":[{"name":"Respiratory Medicine, GIGA I, CHU Sart-Tilman, Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Zanella","sequence":"additional","affiliation":[{"name":"Organic and Biological Analytical Chemistry Group and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Hugues","family":"Stefanuto","sequence":"additional","affiliation":[{"name":"Organic and Biological Analytical Chemistry Group and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Bessonov","sequence":"additional","affiliation":[{"name":"Medical Genomics-BIO3, GIGA-R, University of Liege, Sart-Tilman, Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieska","family":"Smolinska","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W.","family":"Dallinga","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Henket","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, GIGA I, CHU Sart-Tilman, Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Paulus","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, GIGA I, CHU Sart-Tilman, Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Guissard","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, GIGA I, CHU Sart-Tilman, Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Graff","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, GIGA I, CHU Sart-Tilman, Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Moermans","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, GIGA I, CHU Sart-Tilman, Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel F. M.","family":"Wouters","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"Van Steen","sequence":"additional","affiliation":[{"name":"Medical Genomics-BIO3, GIGA-R, University of Liege, Sart-Tilman, Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik-Jan","family":"van Schooten","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Focant","sequence":"additional","affiliation":[{"name":"Organic and Biological Analytical Chemistry Group and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Louis","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, GIGA I, CHU Sart-Tilman, Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,15]]},"reference":[{"key":"2026030321324801600_bib1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/thorax.57.10.875","article-title":"Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids","volume":"57","author":"Green","year":"2002","journal-title":"Thorax"},{"key":"2026030321324801600_bib2","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(99)01813-9","article-title":"Non-eosinophilic corticosteroid unresponsive asthma","volume":"353","author":"Pavord","year":"1999","journal-title":"Lancet"},{"key":"2026030321324801600_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ccm.2012.05.004","article-title":"Corticosteroids: still at the frontline in asthma treatment?","volume":"33","author":"Louis","year":"2012","journal-title":"Clin Chest Med"},{"key":"2026030321324801600_bib4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","article-title":"Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial","volume":"68","author":"Brusselle","year":"2013","journal-title":"Thorax"},{"key":"2026030321324801600_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","article-title":"Clarithromycin targets neutrophilic airway inflammation in refractory asthma","volume":"177","author":"Simpson","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321324801600_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"2026030321324801600_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","article-title":"Inflammatory subtypes in asthma: assessment and identification using induced sputum","volume":"11","author":"Simpson","year":"2006","journal-title":"Respirology"},{"key":"2026030321324801600_bib8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/thx.2009.124925","article-title":"Exhaled nitric oxide thresholds associated with a sputum eosinophil count \u22653% in a cohort of unselected patients with asthma","volume":"65","author":"Schleich","year":"2010","journal-title":"Thorax"},{"key":"2026030321324801600_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1203\/PDR.0b013e3181df4ea0","article-title":"Metabolomics of volatile organic compounds in cystic fibrosis patients and controls","volume":"68","author":"Robroeks","year":"2010","journal-title":"Pediatr Res"},{"key":"2026030321324801600_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.rmed.2009.10.018","article-title":"A profile of volatile organic compounds in breath discriminates COPD patients from controls","volume":"104","author":"Van Berkel","year":"2010","journal-title":"Respir Med"},{"key":"2026030321324801600_bib11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.molmed.2015.08.001","article-title":"Exhaled molecular fingerprinting in diagnosis and monitoring: validating volatile promises","volume":"21","author":"Boots","year":"2015","journal-title":"Trends Mol Med"},{"key":"2026030321324801600_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.5588\/ijtld.11.0576","article-title":"Breath analysis as a potential diagnostic tool for tuberculosis","volume":"16","author":"Kolk","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321324801600_bib13","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/cea.12147","article-title":"Predicting steroid responsiveness in patients with asthma using exhaled breath profiling","volume":"43","author":"van der Schee","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"2026030321324801600_bib14","doi-asserted-by":"crossref","first-page":"027108","DOI":"10.1088\/1752-7155\/6\/2\/027108","article-title":"The versatile use of exhaled volatile organic compounds in human health and disease","volume":"6","author":"Boots","year":"2012","journal-title":"J Breath Res"},{"key":"2026030321324801600_bib15","doi-asserted-by":"crossref","first-page":"016006","DOI":"10.1088\/1752-7155\/10\/1\/016006","article-title":"Volatile organic compounds discriminate between eosinophilic and neutrophilic inflammation in vitro","volume":"10","author":"Schleich","year":"2016","journal-title":"J Breath Res"},{"key":"2026030321324801600_bib16","doi-asserted-by":"crossref","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"Cohen","year":"2016","journal-title":"BMJ Open"},{"key":"2026030321324801600_bib17","author":"Global Initiative for Asthma"},{"key":"2026030321324801600_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2466-13-11","article-title":"Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation","volume":"13","author":"Schleich","year":"2013","journal-title":"BMC Pulm Med"},{"key":"2026030321324801600_bib19","first-page":"24","article-title":"Postmortem internal gas reservoir monitoring using GCXGC-HRTOF-MS","volume-title":"Separations","author":"Stefanuto","year":"2018"},{"key":"2026030321324801600_bib20","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1021\/ac051632c","article-title":"Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures: application in 1H NMR metabonomics","volume":"78","author":"Dieterle","year":"2006","journal-title":"Anal Chem"},{"key":"2026030321324801600_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/cea.13080","article-title":"Priorities for future research into asthma diagnostic tools: a PAN-EU consensus exercise from the European Asthma Research Innovation Partnership (EARIP)","volume":"48","author":"Garcia-Marcos","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"2026030321324801600_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2222.2009.03343.x","article-title":"Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children","volume":"40","author":"Dallinga","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"2026030321324801600_bib23","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1164\/rccm.200906-0939OC","article-title":"Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma","volume":"180","author":"Fens","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321324801600_bib24","author":"Schleich"},{"key":"2026030321324801600_bib25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.rmed.2013.03.011","article-title":"An electronic nose discriminates exhaled breath of patients with untreated pulmonary sarcoidosis from controls","volume":"107","author":"Dragonieri","year":"2013","journal-title":"Respir Med"},{"key":"2026030321324801600_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1472-8206.2007.00469.x","article-title":"How to deal with multiple treatment or dose groups in randomized clinical trials?","volume":"21","author":"Hothorn","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"key":"2026030321324801600_bib27","doi-asserted-by":"crossref","first-page":"046008","DOI":"10.1088\/1752-7155\/5\/4\/046008","article-title":"The application of statistical methods using VOCs to identify patients with lung cancer","volume":"5","author":"Ulanowska","year":"2011","journal-title":"J Breath Res"},{"key":"2026030321324801600_bib28","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1378\/chest.09-1836","article-title":"Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma","volume":"137","author":"Montuschi","year":"2010","journal-title":"Chest"},{"key":"2026030321324801600_bib29","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jaci.2018.10.058","article-title":"Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma","volume":"143","author":"Brinkman","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321324801600_bib30","doi-asserted-by":"crossref","first-page":"1701817","DOI":"10.1183\/13993003.01817-2017","article-title":"Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label","volume":"51","author":"de Vries","year":"2018","journal-title":"Eur Respir J"},{"key":"2026030321324801600_bib31","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/thx.2010.156695","article-title":"Non-invasive phenotyping using exhaled volatile organic compounds in asthma","volume":"66","author":"Ibrahim","year":"2011","journal-title":"Thorax"},{"key":"2026030321324801600_bib32","first-page":"113","article-title":"Induced sputum: towards normal values","volume-title":"Non invasive assessment of airways inflammation in asthma and COPD","author":"Louis","year":"2011"},{"key":"2026030321324801600_bib33","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.119.5.1329","article-title":"Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8","volume":"119","author":"Gibson","year":"2001","journal-title":"Chest"},{"key":"2026030321324801600_bib34","first-page":"573","article-title":"Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics","volume":"50","author":"Buszewski","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"2026030321324801600_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1471-2407-11-226","article-title":"Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8","volume":"11","author":"Carpagnano","year":"2011","journal-title":"BMC Cancer"},{"key":"2026030321324801600_bib36","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ecco-jcc\/jjv102","article-title":"Analysis of exhaled breath volatile organic compounds in inflammatory bowel disease: a pilot study","volume":"9","author":"Hicks","year":"2015","journal-title":"J Crohn\u2019s Colitis"},{"key":"2026030321324801600_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cca.2014.04.030","article-title":"Investigation of potential breath biomarkers for the early diagnosis of breast cancer using gas chromatography-mass spectrometry","volume":"436","author":"Li","year":"2014","journal-title":"Clin Chim Acta"},{"key":"2026030321324801600_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.arbres.2013.04.004","article-title":"Volatile organic compounds in exhaled breath in a healthy population: effect of tobacco smoking","volume":"49","author":"Jare\u00f1o-Esteban","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"2026030321324801600_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12890-016-0208-2","article-title":"Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?","volume":"16","author":"Demarche","year":"2016","journal-title":"BMC Pulm Med"},{"key":"2026030321324801600_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1183\/09031936.00201813","article-title":"Importance of concomitant local and systemic eosinophilia in uncontrolled asthma","volume":"44","author":"Schleich","year":"2014","journal-title":"Eur Respir J"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/200\/4\/444\/67169193\/ajrccm_200_4_444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/200\/4\/444\/67169193\/ajrccm_200_4_444.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:32:58Z","timestamp":1772591578000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/200\/4\/444\/8496853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,8,15]]},"published-print":{"date-parts":[[2019,8,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201811-2210oc","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735535140.793558923","asserted-by":"object"}]},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,8]]}}}